Substance use and psychosis

Auditorium VII
In programme
Wednesday, 23 October, 2024 - 15:00 to 16:30
View presentations

About

The relationships between drug use (and particularly cannabis use) and psychosis have been extensively studied. In this session, speakers from Sweden, Canada and Portugal focus on real-world effectiveness of treatment in community and hospital settings, encompassing the impact of antipsychotic medication on patient experiences and outcomes.

Chair

Farrell Michael
  • Professor,
  • NDARC, UNSW Sydney,
  • Australia

Type

Tracks

Keywords

Presentations

Wednesday, 23 October

15:00
Oral presentation

Antipsychotics and relapse risk in persons with first-episode psychosis and co-occurring cannabis use disorder

15:00 to 16:30
Auditorium VII
Heidi Taipale
Oral presentation

Cannabinoid Use Experience among inpatients with psychotic symptoms – A Cross-Sectional study in a Portuguese Hospital

15:00 to 16:30
Auditorium VII
Carolina Afonso Romano
Oral presentation

Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis

15:00 to 16:30
Auditorium VII
Antti Mustonen
Oral presentation

“Into a whirlwind”: Navigating psychosis and anti-psychotic treatment among youth entrenched in an urban drug scene

15:00 to 16:30
Auditorium VII
Trevor Goodyear
View the programme